{"id":"W4400193376","doi":"10.1136/gutjnl-2024-bsg.23","title":"O23 Risankizumab vs ustekinumab for patients with moderate-to-severe crohn’s disease: results from the phase 3b SEQUENCE study","year":2024,"lang":"en","type":"article","venue":"Oral Presentations","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Ustekinumab; Crohn's disease; Crohn disease; Medicine; Sequence (biology); Internal medicine; Phase (matter); Gastroenterology; Disease; Physics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002561401,0.0008461134,0.001713658,0.0002012915,0.000251164,0.0006812834,0.0004950393,0.001021,0.003930377],"category_scores_gemma":[0.001350071,0.0003212184,0.002279919,0.0002430921,0.0005441114,0.000576581,0.0002779451,0.001862003,0.000768092],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000530575,"about_ca_system_score_gemma":0.001348671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007632425,"about_ca_topic_score_gemma":0.001744419,"domain_scores_codex":[0.9992354,0.0004749283,0.00005494156,0.00007780315,0.00006681513,0.00009013711],"domain_scores_gemma":[0.9989735,0.0002615839,0.0002380372,0.00007349617,0.0000851256,0.0003682273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9453445,0.008588213,0.0008669976,0.0008075128,0.0009751105,0.00004268289,0.00006758623,0.0004838612,0.006747511,0.000107527,0.001477115,0.03449141],"study_design_scores_gemma":[0.7423567,0.2485974,0.005063809,0.00007590919,0.0007277968,0.00009154256,0.000026432,0.0004687627,0.0008677774,0.0002031005,0.001501847,0.00001893353],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865037,0.007457062,0.0004996079,0.0007628239,0.0003327662,0.001497359,0.00104823,0.00007440371,0.001823943],"genre_scores_gemma":[0.9899901,0.003313958,0.001175613,0.00116601,0.0004477333,0.001195476,0.001210819,0.00002234536,0.001477876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003930377,"threshold_uncertainty_score":0.01354617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02450188779997184,"score_gpt":0.321851610683091,"score_spread":0.2973497228831191,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}